Revolutionary technologies are rapidly making their way into the market, bringing with them greater precision, enhanced flexibility and at least when compared to some conventional approaches lower costs. The pace at which these new technologies, their tools and applications, are making their way out of the laboratory and into our hands appears to be accelerating. And while artificial intelligence, and gene editing tools such as the clustered regularly interspaced short palindromic repeats CRISPR system, appear to hold substantial promise, and unparalleled opportunities, great uncertainty exists over their trajectory and